Status:
COMPLETED
Retrospective Observational Study on GERD Management in General Hospitals in Korea
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Conditions:
Gastroesophageal Reflux Disease (GERD)
Eligibility:
All Genders
19+ years
Brief Summary
A RetrospectiVe ObservatIoNal Study of a CurrEnt Status and its Management of GERD (GastroEsophageal Reflux Disease) in General HOspitals in Korea
Detailed Description
This study is designed as a multicenter, retrospective observational study. After signing a contract with the research institution or investigator, patients who meet the inclusion/exclusion criteria i...
Eligibility Criteria
Inclusion
- Patients aged 19 years or older as of the date of their first visit.
- Patients who visited domestic general hospitals (secondary and tertiary healthcare institutions) at least twice between January 1, 2018, and August 31, 2020, for the diagnosis or treatment of GERD.
Exclusion
- Patients with no GERD treatment information recorded in the medical records, even once.
- Patients deemed inappropriate for participation by the investigator (e.g., when the overall GERD diagnosis/treatment information is missing from the medical records).
Key Trial Info
Start Date :
January 3 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
13750 Patients enrolled
Trial Details
Trial ID
NCT06974903
Start Date
January 3 2018
End Date
December 31 2024
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hanyang University Hospital
Seoul, Seongdong-gu, South Korea, 04763